Publications by authors named "P Gimenez Font"

Claim this Profile
P
Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndrome.
James M Foran, Guillermo F Sanz, Justin M Watts, Andrew M Brunner, Gaelle Fossard, Patricia Font

Leuk Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness screening of SARS-CoV-2 (COVID-19) in the municipality of Andratx (Balearic Islands, Spain).
Margalida Monserrat-Mesquida, Maria Magdalena Quetglas-Llabrés, Cristina Bouzas, Silvia García, Patricia Font

Front Public Health· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation of the Oxidant-Free Au(I)/Au(III) Catalysis Enabled by the Hemilabile Ligand Strategy.
Pau Font, Hugo Valdés, Xavi Ribas

Angew Chem Int Ed Engl· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs.
Laura Muñoz-Barrera, Carlos Perez-Sanchez, Rafaela Ortega-Castro, Sagrario Corrales, Maria Luque-Tevar, Pilar Font

Biomed Pharmacother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel NHC-Based Au(I) Complexes as Precursors of Highly Pure Au(0) Nuggets under Oxidative Conditions.
Pau Font, Nikolaos V Tzouras, Argyro T Papastavrou, Georgios C Vougioukalakis, Xavi Ribas

Molecules· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis